TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive In Brief: Twenty-Nine Percent Of Approved Organ Systems Applications Funded In February, May Cycles November 4, 1983
TCL Archive In Brief: AACR Award Lectures, Announced; Hungerford Honored for Philadelphia Chromosome Discovery April 20, 1990
